Article
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.
British journal of clinical pharmacology - 1 Aug 2014
Ji Yuan, Schaid Daniel J, Desta Zeruesenay, Kubo Michiaki, Batzler Anthony J, Snyder Karen, Mushiroda Taisei, Kamatani Naoyuki, Ogburn Evan, Hall-Flavin Daniel, Flockhart David, Nakamura Yusuke, Mrazek David A, Weinshilboum Richard M
Abstract excerpt
AIMS: Citalopram (CT) and escitalopram (S-CT) are among the most widely prescribed selective serotonin reuptake inhibitors used to treat major depressive disorder (MDD). We applied a genome-wide association study to identify genetic factors that contribute to variation in plasma concentrations of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
